§zC£ ï9à tr ôç °^g¼8¼ù|åkn8Oì h- @ p ... · ANVISA - VIGILÂNCIA ... Biol. Chem., v....

REFERÊNCIAS BIBLIOGRÁFICAS

___________________________________________Referências Bibliográficas 159

6. REFERÊNCIAS BIBLIOGRÁFICAS

ALEXOPOULOS, C. J.; MIMS, C. W.; BLACKWELL, M. Introductory

Mycology, 4 ed.; John Willey and Sons, Inc, 1996 cap. 11, p. 294-322.

ALVIANO, C. S.; FARBIARZ, S. R.; TRAVASSOS, L. R.; ANGLUSTER, J.;

SOUZA,W. Effect of environmental factors on Fonsecaea pedrosoi

morphogenesis with emphasis on sclerotic cells induced by propanolol.

Micopathologia, v. 119, p. 17-23, 1992.

ANINAT, C.; HAYASHI, Y.; ANDRÉ, F.; DELAFORGE, M. Molecular

requirements for inhibition of cytochrome P450 activities by roquefortine.

Chem. Res. Toxicol., v. 14, p. 1259-1265, 2001.

ANVISA - VIGILÂNCIA SANITÁRIA - www.anvisa.gov.br (acesso em Maio,

2003)

BAKKER, B. M.; MICHELS; P. A. M.; OPPERDOES, F. R.; WESTERHOFF,

H. V. What controls glycolysis in bloodstream form Trypanosoma brucei? J.

Biol. Chem., v. 274, n. 14, p. 551-559, 1999.

BARROW, C. J.; SEDLOCK, D., M. 1’-(2-phenyl-ethylene)- ditryptophenaline,

a new dimeric diketopiperazine from Aspergillus flavus. J. Nat. Prod., v. 57,

n. 2, p. 1239-1244, 1994.

BASTOS, J.K., ALBUQUERQUE, S., SILVA, M.L.A. Evaluation of the

trypanocidal activity of lignans isolated from the leaves of Zanthoxylum

naranjillo. Planta Med., v. 65, p. 541-544, 1999.

BENNETT, J. W. Mycotechnology: the role of fungi in biotechnology. J.

Biotechnol., v. 66, p. 101-107, 1998.


BERGER, I.; BARRIENTOS, A. C.; CÁCERES, A.; HERNÁNDEZ, M.;

RASTRELLI, L.; PASSREITER, C. M.; KUBELKA, W. Plants used in

Guatemala for the treatment of protozoal infections II. Activity of extracts and

fractions of five Guatemalan plants against Trypanosoma cruzi. J.

Ethnopharmacol. v. 62, p. 107-115, 1998.

BERMAN, J. D. Human leishmaniasis: clinical, diagnostic, and

chemotherapeutic developments in the last 10 years. Clin. Infect. Dis., v. 24,

p. 684-703, 1997.

BIRKINSHAW, J. H.; MOHAMMED, Y. S. Studies in biochemistry of micro-

organisms. III. The production of L-phenylalanine anhydride (cis-L-3,6-

dibenzyl- 2,5-dioxopiperazine) by Penicillium nigricans (Bainier) THOM.

Biochem. J., v. 85, p. 523-527, 1962.

BOCK, B.; PEDERSEN, C. Carbon-13 nuclear magnetic resonance

spectroscopy of monosaccharides. Adv. Carbohydr. Chem. Biochem., v.

41, p. 27-65, 1983.

BOYES-KORKIS, J. M.; GURNEY, K. A.; PENN, J.; MANTLE, P. G. Anacine,

a new benzodiazepine metabolite of Penicillium aurantiogriseum produced

with other alkaloids in submerged fermentation. J. Nat. Prod., v. 56, n. 10, p.

1707-1717, 1993.

BREITMAIER, E.; HASS, G.; VOELTER, W. Atlas of carbon-13 NMR, 1 ed.,

Heyden & Son., Londres, 1979.

BRENER, Z. Therapeutic activity and criterion of cure on mice experimentally

infected with Trypanosoma cruzi. Rev. Inst. Med. Trop., v. 4, p. 389-396,

1962.


__________. Biology of Trypanosoma cruzi. Annu. Rev. Microbiol., v. 27, p.

347-382, 1973.

BRINGMANN, G.; MADER, T. In vivo formation of diazepam-like 1,4-

benzodiazepines by Penicillium verrucosum var. verrucosum after

administration of 2-aminobenzophenones and glicine. J. Neural. Transm.

[Gen. Sect.], v. 101, p. 169-181, 1995.

BURLEIGH, B. A.; ANDREWS, N. W. A 120-kda alkaline peptidase from

Trypanosoma-cruzi is involved in the generation of a novel ca2+ signaling

factor for mammalian-cells. Annu. Rev. Microbiol., v. 49, p. 175-200, 1995.

BURTON, A. Miltefosine-oral victory over visceral leishmaniasis. Lancet

Infect. Dis., v. 3, p. 64, 2003.

CERECETTO, H.; MAIO, R. D.; IBARRURI, G.; SEOANE, G.; DENICOLA,

A.; PELUFFO, G.; QUIJANO, C.; PAULINO, M. Synthesis and trypanosomal

activity of novel 5-nitro-2-furaldehyde and 5-nitrothiophene-2-carboxaldehyde

semicarbazone derivatives. II Farmaco, v. 53, p. 89-94, 1998.

COLLINS,P.; FERRIER, R. Monosaccharides - Their chemistry and their

roles in natural products, 2 ed., 1996.

COURA, J. R.; CASTRO, S. L. A critical review on Chagas Diease

chemotherapy. Mem. Inst. Oswaldo Cruz, v. 97, n. 1, p. 3-24, 2002.

CROAN, D.; ELLIS, J. Phylogenetic relationships between Leishmania

viannia and Sauroleishmania inferred from comparison of a variable domain

within the RNA polymerase II largest subunit gene. J. Mol. Biochem.

Parasitol., v. 79, p. 97-102, 1996.


CROFT, S. L. Pharmacological Approaches to Antitrypanosomal

Chemotherapy. Mem. Inst. Oswaldo Cruz, v. 94, n. 2, p. 215-220, 1999.

CROFT, S. L.; SEIFERT, K.; DUCHÊNE, M. Antiprotozoal activities of

phospholipid analogues. Mol. Chem. Parasitol., v. 126, p. 165-172, 2003.

DEMAIN,A.L. Pharmaceutically active secondary metabolites of

microorganisms. Appl. Microbiol. Biotechnol., v. 52, p. 455-463, 1999.

__________. Microbial biotechnology Trends in Biotechnol., v. 18, p. 26-

31, 2000.

DEMOURA, K. C. G.; EMERY, F. S.; NEVESPINTO, C. ; PINTO, M. C. F. R.;

DANTAS, A. P.; SALOMÃO, K.; CASTRO, S. L.; PINTO, A. V. J.

Trypanocidal activity of isolated naphthoquinones from Tabebuia and some

heterocyclic derivatives: A review from an interdisciplinary study. J. Braz.

Chem. Soc., v. 12, p. 325-338, 2001.

DOCAMPO, R.; SCHMUÑIS, C. A. Sterol biosynthesis inhibitors potencial

chemotherapeutics against Chagas diease. Parasitol. Today, v. 13, p. 127-

128, 1997.

DOCAMPO, R. Recent developments in the chemotherapy of Chagas’

Disease. Curr. Pharm. Des., v. 7, p. 1157-1164, 2001

ENGEL, J. C.; FRANKE DE CAZZULO, B. M.; STOPPANI, A. O.;

CANNATTA, J. J.; CAZZULLO, J. J. Aerobic glucose fermentation by

Trypanosoma cruzi axenic culture amastigote-like forms during growth and

differentiation to epimastigotes. Mol. Biochem. Parasitol. v. 26, p. 1-10,

1987.


ENZYME COMMISSION - http://us.expasy.org/enzyme (Acesso em

março/2003

ESCOBAR, P.; SANGEETA, M.; MARQUES, C.; CROFT, S. L. Sensitivities

of Leishmania species to hexadecylphosphocholine (miltefosine), ET-18-

OCH3 (edelfosine) and amphotericin B. Acta Trop., v. 81, p. 151-157, 2002.

FAIRLAMB, A. H. Future prospects for the chemotherapy of Chagas’

disease. Medicina (Buenos Aires), v. 59, Suppl.II, p. 179-187, 1999.

FALORNI, M.; PORCHEDDU, A.; GIACOMELLI, G. Syntheis of (2R,5S)- and

(2S,5S)-2-carboxy-1,4-diaza-[4.3.0]bicyclonone as building blocks for the

synthesis os new potencial HIV protease inhibitors. Tetrahedron Asym., v.

7, n. 7, p. 1999-2005, 1996.

FARMACOPÉIA BRASILEIRA Métodos biológicos, 4 ed. São Paulo, 1988.

FEREZOU, J. P.; THIERRY, A. Q.; BARBIER, M. Structure and synthesis of

phomamide,a nw piperazine-2,5-dione related to the sirodesmins,isolated

from culture medium of Phomalingam Tode. J. Chem. Soc. Perkin I, p. 113-

115, 1979.

FISCHER, G.; SCHWALBE, R.; MÖLLER, M.; OSTROWSKI, R.; DOTT, W.

Species-specific production of microbial volatile organic compounds (MVOC)

by airborne fungi from a compost facility. Chemosphere, v. 39, p. 795-810,

1999.

FRAYHA, G. J.; SMYTH, J. D.; GOBERT, J. G.; SAVEL, J. The mechanisms

of action of antiprotozoal and anthelmintic drugs in man. Gen. Pharmacol.,

v. 28, n. 2, p. 273-299, 1997.


FREIBURGHAUS, F.; KAMINSKY, R.; NKUNYA, M. H. H.; BRUN, R.

Evaluation of african medicinal plants for their in vitro trypanocidal activity. J.

Ethnopharmacol., v. 55, p. 1-11, 1996.

FREITAS, T. P. S.; FURTADO, N. A. J. C., BASTOS, J. K.; SAID, S. Active

substances against trypomastigote forms of Trypanosoma cruzi and

microorganisms are produced in sequence by Talaromyces flavus.

Microbiol. Res., v. 157, n. 3, p. 201-206, 2002.

FRISVAD J. C., THRANE U. Standardised High-Performance Liquid

Chromatography of 182 mycotoxins and other fungal metabolites based on

alkylphenone retention indices and UV-VIS spectra (Diode Array Detection).

J. Chromatogr., v. 404, p. 195-214, 1987.

FRISVAD J. C. High-performance liquid chromatographic determination of

profiles of mycotoxins and other secondary metabolites. J. Chromatogr., v.

392, p. 333-347, 1987.

FURTADO, N. A. J. C.; SAID, S.; BASTOS, K. Determination of optimum

growth conditions for antibiotic production in different media by Aspergillus

fumigatus. Resumo P4.4 em Eur. J. Pharm. Sci., v. 13, Suppl I, p. 38, 2001.

FUSKA, J.; NEMEC, P.; HUHR, I. Vermiculine, a new antiprotozoal antibiotic

from Penicillium vermiculatum. J. Antibiot., p. 208-211, 1972.

GADEN, E. L Fermentation process kinetics. J. Biochem. Microbial.

Technol. Eng. I, v. 1, n. 4, p. 413-418, 2000.

GADEN-JUNIOR, E. L. Fermentation process kinetics. Biotechnol. Bioeng.,

v. 67, n. 6, p. 629-635, 2000.


GARCIA – SILVA, M.; FURTADO, N. A. J. C.; FONSECA, M. J. V.; BASTOS,

K. Antimicrobial activity of secondary metabolites obtained from Penicillium

corylophilum submitted to different fermentative media. Resumo P4.3 em

Eur. J. Pharm. Sci., v. 13, Suppl I, p. 38, 2001.

GARCIA – SILVA, M. Penicillium corylophilum Dierck - Atividades

antimicrobiana e antichagásica de extratos brutos e metabólitos secundários

isolados. Dissertação de Mestrado. Faculdade de Ciências Farmacêuticas

de Ribeirão Preto-USP, Ribeirão Preto, 2002.

GEARY, T. G., EDGAR, A.; JENSEN, J. B. In Campbell, W. C. and Rew, R.

S. (eds.), Chemoterapy of Parasitic Diseases, Plenum Press, New York, p.

209-238, 1989.

GIL, A. M.; BELTON, P. S.; FELIX, V. Spectroscopy studies of solid α,α-

trehalose. Spectrochimica Acta Part A, v. 52, p. 1649-1659, 1996.

GÖHRT, A.; ZEECK, A. Secondary metabolites by chemical screening. 9

Decarestrictines, a new family of inhibitors of cholesterol biosynthesis from

Penicillium. J. Antibiot., p. 66-73, 1992.

GRABLEY, S.; GRANZER, E.; HUTTER, K.; LUDWIG, D.; MAYER, M.;

THIERICKE, R.; TILL, G.; WINK, J. Secondary metabolites by chemical

screening. 8 decarestrictines, a new family of inhibitors of cholesterol

biosynthesis from Penicillium. J. Antibiot., v. 45, p. 56-65, 1992.

GRIFFIN, D. H. Antimicrobial Chemotherapy. 2 ed. New York, John Willey

and Sons, p. 458, 1994.

GUGLIELMINETTI, M.; VALOTI, E.; CASSINI, P.; TAIANO, G.; CARETTA,

G. Respiratory syndrome very similar to extrinsic allergic alveolitis due to


Penicillium verrucosum in workers in a cheese factory. Mycopathologia, v.

149, p. 123-129, 2000.

GÜRTLER, R. E.; SEGURA, E. L.; COHEN, J. E. Congenital transmission of

Trypanosoma cruzi infection in Argentina. Emerg. Infect. Dis., v. 9, n. 1,

2003.

HAINES, A. H. Synthesis of L-trehalose and observations on isomer and by-

product formation. Carbohyd. Res., v. 338 (in press), 2003.

HARVEY, A. Strategies for discovering drugs from previously unexplored

natural products. Drug. Discov. Today., v. 5, n. 7, p. 294-300, 2000.

HODGE, R. P.; HARRIS, C. M.; HARRIS, T. M. Verrucofortine, a major

metabolite of Penicillium verrucosum Var. cyclopium, the fungus that

produces the mycotoxin verrucosidin. J. Nat. Prod., v. 51, n. 1, p. 66-73,

1988.

JACKSON, M.; KARWOSWSKI, J. P.; HUMPHREY, P. E.; KOHL,W. L.;

BARLOW, G. J.; TANAKA, S. K. Calbistrins, novel antifungal agents

produced by Penicillium restrictum J. Antibiot., v. 46, p. 34-38, 1993.

KAYSER, O.; KIDERLEN, A. F.; LAATSCH, H.; CROFT, S. L. In vitro

leishmanicidal activity of monomeric and dimeric naphthoquinones. Acta

Trop., v. 77, p. 301-314, 2000.

KENDALL, G. Biochem. Soc. Trans., v. 16, p.1067, 1988

KHABNADIDEH, S.; TAN, C. L.; CROFT, S. L.; KENDRICK, H.; YARDLEY,

V.; GILBERT, I. H. Squalamine analogues as potencial ati-trypanosomal and

anti-leishmanial compounds. Biorg. Med. Chem. Lett., v. 10, p. 1237-1239,

2000.


KONSTANTINOV, S. M.; KAMINSKY, R.; BRUN, R.; BERGER, M. R.;

ZILLMANN, U. Efficacy of anticancer alkylphosphocholines in Trypanosoma

brucei subspecies. Acta Trop., v. 64, p. 145-154, 1997.

KOSEMURA, S.; UOTSU, S.; YAMAMURA, S. Citreospirosteroid, a new

metabolite of a hybrid strain KO 0011 derived from Penicillium citreo-viride B.

IFO 6200 and 4692. Tetrahedron Lett., v. 38, n. 42, p. 7373-7374, 1997.

KOZLOVSKY, A. G.; VINOKUROVA, N., G.; ADANIN, V. M.; SEDMERA, P.

Secondary metabolites of various strains of Penicillium fellutanum. Appl.

Biochem. Microbiol., v. 33, n. 4, p. 364-369, 1997.

KOZLOVSKY, A. G.; VINOKUROVA, N., G.; ADANIN, V. M. Diketopiperazine

alkaloids from the fungus Penicillium piscarium Westling. Appl. Biochem.

Microbiol., v. 36, n. 3, p. 271-275, 2000a.

KOZLOVSKY, A.G.; VINOKUROVA, N.G.; ADANIN, V.M.; BURKHARDT, G.;

DAHSE, H.; GRÄFE,U. New diketopiperazine alkaloids from Penicillium

fellutanum. J. Nat. Prod., v. 63, p. 698-700, 2000b.

KOZLOVSKY, A. G.; ADANIN, V. M.; DAHSE, H. M.; GRAFE, U.

Rugolosuvines A and B, diketopiperazine alkaloids of Penicillium rugulosum

and Penicillium piscarium fungi. Appl. Biochem. Microbiol., v. 37, n. 3, p.

253-256, 2001.

KWON, O. S.; PARK, S. H.; YUN, B. S.; PYUN, Y. R.; KIM, C. J. Cyclo

(dehydroala-l-Leu) an α-glucosidase inhibitor from Penicillium sp. F70614. J.

Antibiot., v. 53, n. 9, p. 954-958, 2000.


LAI, S.; SHIZURI, Y.; YAMAMURA, S.; KAWAI, K.; FURUKAYA, H. Three

new phenolic metabolites from Penicillium species. Heterocycles. v. 32, n. 2,

p. 297-305, 1991.

LARSEN, T. O.; FRISVAD, J. C.; JENSEN, S. R. Aurantiamine, a

diketopiperazine from two varieties of Penicillium aurantiogriseum.

Phytochemistry, v. 31, n.5, p. 1613-1615, 1992

LARSEN T. O.; FRISVAD, J.; CHRISTOPHERSEN, C. Arabenoic acid

(verrucolone), a major chemical indicator of Penicillium verrucosum.

Biochem. Syst. Ecol., v. 26, p. 463-465, 1998a.

LARSEN, T. O.; FRYDENVANG, K.; FRISVAD, J. C.; CHRISTOPHERSEN,

C. UV-guided isolation of alantrypinone, a novel Penicillium alkaloid. J. Nat.

Prod., v. 31, n. 5, p. 1613-1615, 1998b.

LARSEN, T. O.; FRANZYK, H.; JENSEN, S.R. UV-guided isolation of

verrucines A and B, novel quinazolines from Penicillium verrucosum

structurally related to anacine from Penicillium aurantiogriseum. J. Nat.

Prod., v. 62, p. 1578-1580, 1999a.

LARSEN, T. O.; SMEDSGAARD, J.; FRISVAD, J. C.; ANTHONI, U.;

CHRISTOPHERSEN, C. Consistent production of penigequinolone A and B

by Penicillium scabrosum. Biochem. Syst. Ecol., v. 27, p. 329-332, 1999b.

LARSEN, T. O.; FRYDENVANG, K.; FRISVAD, J. C. UV-guided screening of

benzodiazepine producing species in Penicillium. Biochem. Syst. Ecol., v.

28, p. 881-886, 2000.

LARSEN, T. O.; PETERSEN, B. O.; DUUS, J. Lumpidin, a novel biomarker of

some ochratoxin A producing penicillia. J. Agric. Food Chem., v. 49, n. 10,

p. 5081-5084, 2001.


LARSEN, T. O.; GAREIS, M.; FRISVAD, J.C. Cell cytotoxity and mycotoxin

and secondary metabolite production by common penicillia on cheese agar.

J. Agric. Food. Chem., v. 50, p. 6148-6152, 2002.

LAWS, I.; MANTLE, P. G. Nigrifortine, a diketopiperazine metabolite of

Penicillium nigricans. Phytochemistry, v. 24, n. 6, p. 1395-1397, 1985.

LEE, S.; SU, W.; LIU, K. C. S. C. Cyclopeptide alkaloids from stems of

Paliurus ramossisimus. Phytochemistry, v. 58, p. 1271-1276, 2001.

LI, W. R.; PENG, S. Z. Rational design and synthesis of unsaturaded 2,5-

dioxopiperazine derivatives as potencial protein tyrosine kinase inhibitors.

Tetrahedron. Lett., v. 39, p. 7373-7376, 1998.

MACIAS, F. A.; VARELA, R. M.; SIMONET, A. M.; CETLER, H. G.; CUTLER,

S. J.; ROSS, S. A.; DUNBAR, D. C.; DUGAN, F. M.; HILL, R. A. (+)-Brevione

A. The first member of a novel family of bioactive spiroditerpenoids isolates

from Penicillium brevicompactum Dierckx. Tetrahedron Lett., v. 41, p. 2683-

2686, 2000.

MAFEZOLI, J.; VIEIRA, P. C.; FERNANDES, J. B.; DA SILVA, M. F. G. F.;

ALBUQUERQUE, S. In vitro activity of Rutaceae species against the

trypomastigote form of Trypanosoma cruzi. J. Ethnopharmacol. , v. 73, p.

335-340, 2000.

MAGAN, N.; EVANS, P. Volatiles as an indicator of fungal activity and

differentiation between species, and the potential use of electronic nose

technology for early detection of grain spoilage. J. Stor. Prod. Res., v. 36, p.

319-340, 2000.


MALMSTROM, J.; CHRISTOPHERSEN, C.; FRISVAD, J. Secondary

metabolites characteristic of Penicillium citrinum, Penicillium steckii and

related species. Phytochemistry , v. 54, p. 301-309, 2000.

MANTLE, P. G.; SHIPSTON, N., F. Temporal separation of steps in the

biosynthesis of verruculogem. Biochem. Internat., v. 14, n. 6, p. 1115-1120,

1987.

MARTIN, A. R. Anti-infective agents. In: DELGADO, J. N. E.; REMERS, W.

A., eds. Textbook of organic medicinal and pharmaceutical chemistry.

Philadelphia:Lippincott-Raven, 1998, p. 185.

MARTINEZ, S.; MAAR, J. J.N. Engl. J. Med., v. 326, p. 741-44, 1992.

MARTINEZ-DIAZ, R. A.; ESCARIO, J. A.; NOGAL-RUIZ, J. J.; GOMEZ-

BARRIO, A. Biological characterization of Trypanosoma cruzi strains. Mem.

Inst. Oswaldo Cruz, v. 96, n. 1, p. 53-59, 2001.

MAYER,M. A non-enzymatic reaction in the late biosynthesis of the

decarestrictine family. J. Antibiot., p. 1372-1380, 1993.

MCGREEVY, P. B.; MARSDEN, P. D. In Campbell, W. C. and Rew, R. S.

eds., Chemoterapy of Parasitic Diseases, Plenum Press, New York, p.

115-127,1986.

MEDENTSEV, A. G.; AKIMENKO, V. K. Fungal naphthoquinone metabolites.

Appl. Biochem. Microbiol., v. 32, p. 7-29, 1996.

________________________________. Naphthoquinone metabolites of the

fungi. Phytochemistry, v. 47, p. 935-959, 1998.


MOIDEEN, S. V. K.; HOUGHTON, P. J.; ROCK, P.; CROFT, S. L.,

ABOAGYE-NYAME, F. Activity of extracts and naphthoquinones from Kigelia

pinnata against Trypanosoma brucei brucei and Trypanosoma brucei

rhodesiense. Planta Med., v. 65, p. 536-540, 1999.

MURTA, S. M. F.; GAZZINELLI, R. T.; BRENER, Z.; ROMANHA,A. J.

Molecular characterization of susceptible and naturally resistant strains of

Trypanosoma cruzi to benznidazole and nifurtimox. Mol. Biochem.

Parasitol., v. 93, p. 203-214, 1998.

MUSUKU, A.; SELALA, M. I.; BRUYNE, T.; CLAEYS, M.; SCHEPENS, P. J.

C. Isolation and structure determination of a new roquefortine-related

mycotoxin from Penicillium verrucosum var. Cyclopium isolated from

Cassava. J. Nat. Prod., v. 57, p. 983-987, 1994.

NAM, J.; KIM, H.; KWON, J.; HAN, M. Y.; SON, K.; LEE, U. C.; CHOI, J.;

KNOW, B. 8-O-Methylsclerotiorinamine, antagonist of the Grb2-SH2 domain,

isolated from Penicillium multicolor. J. Nat. Prod., v. 63, p. 1303-1305, 2000.

NEMEC, P.; KRIZKOVÁ, L.; BAL, J.; BALANOVA, J.; KUTKOVÁ, M.

Incidence of antiprotozoal and antivermal antibiotics in fungi.I class fungi

imperfecti. J. Antibiot., p. 345-350, 1969.

NEWMAN, D. J.; CRAGG, G. M.; SNADER, K. M. The influence of natural

products upon drug discovery. Nat. Prod. Rep., v. 17, p. 215-234, 2000.

NOZAWA, K.; UDAGAWA, S. I.; NAKAJIMA, S.; KAWAI, K. I. A

dioxopiperazine derivative from Penicillium megasporum. Phytochemistry,

v. 28, n. 3, p. 929-931, 1989.


OLIVEIRA, R. B.; PASSOS, A. P. F.; ALVES, R. O.; ROMANHA, A.; PRADO,

M. A. F.; FILHO, J. D. S.; ALVES, R. J. In vitro evaluation of the activity of

aromatic nitricompounds against Trypanosoma cruzi. Mem. Inst. Oswaldo

Cruz, v. 98, n. 1, p. 141-144, 2003.

OLLIARO, P. L.; RIDLEY, R. G.; ENGEL, J.; SINDERMANN, H.;

BRYCESON, A. D. M. Miltefosine in visceral leishmaniasis. Lancet Infect.

Dis., v. 3, p. 70, 2003.

OPPERDOES, F. R.; BORST, P. Localization of nine glycolytic enzymes in a

microbody-like organelle in Trypanosoma brucei: the glycossome. FEBS

Lett., v. 80, p. 360-364, 1977.

OPPERDOES, F. R. Compartmentation of carbohydrate metabolism in

trypanosomes. Ann. Rev. Microbiol., v. 41, p. 127-151, 1987.

PALELLA, T. D.; FOX, I. H. In SCRIVER, C. S., BEAUDET, A. L., SLY, W.

S.; VALLE, D. (eds.), The metabolic basis of inherited diseases, McGraw-

Hill, New York, p. 965-1006, 1989.

PAVÃO, F.; CASTILHO, M. S.; PUPO, M. T.; DIAS, R. L. A.; CORREA, A.

G.; FERNANDES, J. B.; DA SILVA, M. F. G. F.; MAFEZOLI, J.; VIEIRA, P.

C.; OLIVA, G. Struture of Trypanosoma cruzi glycosomal glyceraldehyde-3-

phosphate dehydrogenase complexed with a natural product inhibitor at 1.95

Å resolution. FEBS Lett., 2002.

PEARCE, C. Biologically active fungal metabolites. Adv. Appl. Microbiol., v.

44, p. 1-80, 1997.

PEDRAS, M. S. C.; BIESENTHAL, C. J. HPLC analyses of cultures of

Phoma ssp: Differentiation amoung groups and species through secondary

metabolites profiles. Can. J. Microbiol., v. 46, p. 685-691, 2000.


PETSKO, G. A. For medicinal purposes. Nature, v. 384, p. 7-9, suppl., 1996.

PITT, J. I. The current role of Aspergillus and Penicillium in human and

animal health. J. Med. Vet. Mycol., v. 32, n. l, p. 17-32, 1994.

PLACERES NETO, A. Busca de compostos de partida para novas drogas

antichagásicas: estudo fitoquímico de espécies de Rapanea monitorado por

ensaios bioquímicos na busca de inibidores da enzima glicolítica

gliceraldeído-3-fosfato desidrogenase de T. cruzi. Dissertação de Mestrado -

Departamento de Química, UFSCar, São Carlos, 2000.

PRASAD, C. Bioactive cyclic dipeptides. Peptides, v. 16, n. 1, p. 151-164,

1995.

PUPO, M. T.; Constituintes químicos de Trichilia claussenii (Meliaceae).

Tese de Doutorado-Departamento de Química, UFSCar, São Carlos, 1997.

RAHBAEK, L.; SPERRY, S.; FRISVAD, J. C.; LARSEN, T. O. PC-2, LL-

P888gamma and some novel analogue alpha-pyrones from Penicillium

nordicum, P. verrucosum and P. olsonii. Biochem. Syst. Ecol., v. 31, p. 313-

317, 2003.

RAVIKANTH, V.; NIRANJAN REDDY, V. L.;RAMESH, P.; RAO, T. P.;

DIWAN, P. V.; KHAR, A.; VENKATESWARLU, Y. An immunosuppresive

tryptophan-derived alkaloid from Lepidagathis cristata. Phytochemistry, v.

58, p. 1263-1266, 2001.

REINHARD, H.; ZIMMERLI, B. Reversed-phase liquid chromatographic

behavior of the mycotoxins citrinim and ochratoxin A. J. Chromatogr. A, v.

862, p. 147-159, 1999.


ROBBERS, J. E.; SPEEDIE, M. K.; TYLER, V. E. Pharmacognosy and

Pharmacobiotecnology. Baltimore: Williams & Wilkins, p.2-3, 1996.

RODRIGUES, C. O.; DUTRA, P. M. L.; SOUTO-PADÓN, T.; CORDEIRO, R.

S. B.; LOPES, A. H. C. S. Effect of platelet-activating factor on cell

differentiation of Trypanosoma cruzi. Biochem. Biophys. Res. Commun., v.

223, p. 735-740, 1996.

RODRIGUEZ, J. B.; ZHONG, L.; DOCAMPO, R.; WIMMER, Z.; GROS, E. G.

Growth inhbitory effect of juvenile hormone analogues on epimastigotes of

trypanosoma cruzi. Bioorg. Med. Chem. Lett., v. 8, p. 3257-3260, 1998.

RODRIGUEZ, J. B. Specific molecular targets to control tropical diseases.

Curr. Pharm. Des., v.7, p. 125-133, 2001.

ROUSH, W. R.; GONZÁLEZ, F. V.; MCKERROW, J. H.; HANSELL, E.

Design and synthesis of dipeptidyl alpha, beta-epoxy ketones, potent

irreversible inhibitors of the cysteine protease cruzi. Bioorg. Med. Chem.

Lett., v. 8, p. 2809-2812, 1998.

SAJID, M.; McKERROW, J. H. Cysteine proteases of parasitic organisms.

Mol. Biochem. Parasitol., v. 120, p. 1-21, 2002.

SALMON, L.; LANDRY, V.; MELNYK, O.; MAES, L.; SHERGHERAERT, C.;

DAVIOUD-CHARVET, E. A general approach to the synthesis of polyamine

linked-monoindolylmaleimides, a new series of trypanothione reductase

inhibitors. Chem. Pharm. Bull., v. 46, p. 707-710, 1998.

SANTOS, D. A. P. Isolamento e identificação de metabólitos secundários de

fungos comestíveis Agaricus blazei e Ganoderma lucidum. Dissertação de

Mestrado - Departamento de Química, UFSCar, São Carlos, 2001.


SCHUSTER, R.; HOLZHÜTTER, H. G. Use of mathematical-models for

predicting the metabolic effect of large-scale enzyme-activity alterations -

application to enzyme deficiencies of red-blood-cells Eur. J. Biochem., v.

229, p. 403-18, 1995.

SEPÚVELDA-BOZA, S.; CASSELS, B. K. Plant metabolites active against

Trypanosoma cruzi. Planta Med., v. 62, p. 98-105, 1996.

SHIGEMORI, H.; WAKURI, S.; YAZAWA, K.; NAKAMURA, T.; SASAKI, T.;

KOBAYASHI, J. Fellutamides A and B, cytotoxic peptides from a marine fish-

prossessing fungus Penicillium fellutanum. Tetrahedron, v. 47, n. 40, p.

8529-8534, 1991.

SILVA, L. H. P.; NUSSENZWEIG, V. (1953) Sobre uma cepa de

Trypanosoma cruzi altamente virulenta para o camundongo branco. Fol.

Clin. Biol., v. 20, p. 191-8, 1953.

SILVEIRA, V. D. Micologia. 5 ed. Âmbito Cultural Edições Ltda, 1995, cap.

2, p. 17-32.

SMEDSGAARD, J. Micro-scale extraction procedure for standardized

screening of fungal metabolite production in cultures. J. Chromatogr. A, v.

760, p. 264-270, 1997.

SOLOV’EVA, T. F.; BASKUNOV, B., P.; RESHETILOVA, T. A. Puberulin A: a

new diketopiperazine alkaloid of the fungus Penicillium rugulosum THOM

VKM F-352. Appl. Biochem. Microbiol., v. 33, n. 1, p. 57-60, 1997.

SÖRENSEN, D.; LARSEN, T. O.; CHRISTOPHERSEN, C.; NIELSEN, P. H.;

ANTHONI, U. Dipodazine, a diketopiperazine from Penicillium dipodomyis.

Phytochemistry, v. 51, p. 1181-1183, 1999.


SOUZA, D. H. F.; GARRAT, R. C.; ARAÚJO, A. P. U.; GUIMARÃES, B. G.;

JESUS, W. D. P.; MICHELS, P. A. M.; HANNAERT, V.; OLIVA, G.

Trypanosoma cruzi glycosomal glyceraldehyde-3-phosphate dehydrogenase:

structure, catalytic mechanism and targeted inhibitor design. FEBS Lett., v.

424, p. 131-135, 1998.

STACK, M. E.; EPPLEY, R. M.; DREIFFUS, P. A.; POHLAND, A. E. Isolation

and identification of xanthomegnin, viomellein, rubrosulfin, and viopurpurin as

metabolites of Penicillium-viridicatum. Appl. Environ. Microbiol., v. 33, p.

351-355, 1977.

STEFANO, S. D.; NICOLETTI, R.; MILONE, A.; ZAMBARDINO, S. 3-o-

Methylfunicone, a fungitoxic metabolite produced by the fungus Penicillium

pinophilum. Phytochemistry, v. 52, p. 1399-1401, 1999.

STOPPANI, A. O. M. Quimioterapia de la enfermedad de Chagas. Medicina

(Buenos Aires), v. 59, Supl. II, p. 147-165, 1999.

STROHL, W. R. The role of natural products in a modern drug discovery

program. Drug Discov. Today, v. 5, n. 2, p. 39-41, 2000.

TAKAHASHI, C.; NUMATA, A.; YAMADA, T.; MINOURA, K.; ENOMOTO, S.;

KONISHI, K.; NAKAI, M.; MATAUDA, C.; NOMOTO, K. Penostas, novel

cytotoxic metabolites from a Penicillium species separated from a green alga.

Tetrahedron Lett., v. 37, n. 5, p. 655-658, 1996.

TAKEUCHI, M.; NAKAJIMA, M.; OGITA, T.; INUKAI, M.; KODAMA, K.;

FURUYA, K.; NAGAKI, H.; HANEISHI, T. Fosfonocholorin, a new antibiotic

with spheroplast forming activity. J. Antibiot., v. XLII, p. 198-205, 1989.


TENOVER, F. C. Development and spread of bacterial resistance to

antimicrobial agent: an overview. Clin. Infect. Dis., v. 33, S108-S115, 2001.

TOMAZELA, D. M.; PUPO, M. T.; PASSADOR, E. A. P.; SILVA, M. F. G. F.;

VIEIRA, P. C.; FERNANDES, J. B.; RODRIGUES Fo., E.; OLIVA, G.;

PIRANI, J. R. Pyrano chalcones and a flavone from Neoraputia magnifica

and their Trypanosoma cruzi glycosomal glyceraldehyde-3-phosphate

dehydrogenase-inhibitory activities. Phytochemistry, v. 55, p. 643-651,

2000.

THIERICKE, R. a Non-enzymatic reaction in the late biosíntesis of the

decarestrictine family. J. Antibiot., v. 46, p. 1372-1380, 1993.

THIEMANN, O. H.; ALFONZO, J. D.; SIMPSON, L. Cloning and

characterization of Leishmania tarentolae adenine phosphoribosyltransferse.

Mol. Biochem. Parasitol., v. 95, p. 141-146,1998.

TUTTLE, J. V.; KRENISTSKY, T. A. Purine Phosphoribosyltransferases from

Leishmania donovani. J. Biol. Chem., v. 255, n. 3, p. 909-915, 1990.

TYLER, K. M.; ENGMAN, D. M. The life cycle of Trypanosoma cruzi

revisited. Inter. J. Parasitol., v. 31, p. 472-481, 2001.

ULLMAN, B.; CARTER, D. Hypoxanthine-guanine

phosphoribosyltransferase as a therapeutic target in protozoal infections.

Infect. Agents Dis., v. 4, p. 29-40, 1995.

URBINA, J. A.; MARCHAN, E.; LAZARDI, K.; APITZ-CASTRO, R.; GIL, F.;

AGUIRRE, T.; PIRAS, M. M.; PIRAS, R. Inhibition of phosphatidylcholine

biosynthesis and cell-proliferation in Trypanosoma cruzi by ajoene, an

antiplatelet compound isolated from garlic. Biochem. Pharmacol., v. 45, p.

2381-2387, 1993.


URBINA, J. A. Chemoterapy of Chagas’ Disease: the how and the why. J.

Mol. Med. v. 77, p. 332-338, 1999.

URBINA, J. A.; PAYARES, G.; SANOJA, C.; MOLINA, J.; LIRA, R.;

BRENER, Z.; ROMANHA, A. J. Parasitological cure of acute and chronic

experimental Chagas Disease using the long-acting experimental triazole

TAK-187. Activity against drug-resistant Trypanosoma cruzi strains. Int. J.

Antimicrob. Agents, v. 21, p.39-48, 2003

VENDEVILLE, S.; BOUREl, L.; DAVIOUD-CHARVET, E.; GRELLIER, P.;

DEPREZ, B.; SHERGHERAERT, C. Automated parallel synthesis of a

tetrahydroisoquinolin-based library: Potential prolyl endopeptidase inhibitors.

Bioorg. Med. Chem. Lett., v. 9, p. 437-442, 1999.

VERDINE, G. L. The combinatory chemistry of nature. Nature, v. 384, p. 11-

13 suppl., 1996.

VIEIRA, P. C.; MAFEZOLI, J.; PUPO, M. T.; FERNANDES, J. B.; SILVA, M.

F. G. F.; ALBUQUERQUE, S.; OLIVA, G.; PAVÃO, F. Strategies for the

isolation and identification of trypanocidal compounds from the Rutales. Pure

Appl. Chem. v. 73, p. 617-622, 2001.

VOGEL, H. J. A convenient medium for Neurospora (medium N). Microbiol.

Gen. Bull., v. 13, p. 42, 1956.

WEISS, C. R.; MOIDEEN, S. V. K; CROFT, S. L.; HOUGHTON, P. J. Activity

of extracts and isolated naphthoquinones from Kigelia pinnata against

Plasmodium falciparum. J. Nat. Prod., v. 63, p. 1306-1309, 2000.

WHO - World Health Organization Statiscal Information System Website-

http://www.who.ch (Acesso em Maio/2003)


WILLIAMS, D. H.; STONE, M. J.; HAUCK, P. R.; RAHMAN, S. K. Why are

secondary metabolites (natural products) biosynthesized? J. Nat. Prod., v.

52, n. 6, p. 1189-1208, 1989.

YANG, L.; TAN, R.; WANG, Q.; HUANG, W.; YIN, Y. Antifungal

cyclopeptides from Halobacillus litoralis YS3106 of marine origin.

Tetrahedron Lett., v. 43, p. 6545-6548, 2002

ZUCCOTTO, F.; BRUM, R.; PACANOWSKA, D. G.; PEREZ, L. M. R.;

GILBERT, I. H. The struture-based desing and synthesis of selective

inhibitors of Tripanosoma cruzi dihydrofolate reductase. Bioorg. Med.

Chem. Lett., v. 9, p. 1463-1468, 1999.

www.aist.go.jp (Acesso Maio/2003)

§zC£ ï9à tr ôç °^g¼8¼ù|åkn8Oì h- @ p ... · ANVISA - VIGILÂNCIA ... Biol. Chem., v....

Documents

Transcript of §zC£ ï9à tr ôç °^g¼8¼ù|åkn8Oì h- @ p ... · ANVISA - VIGILÂNCIA ... Biol. Chem., v....